AXINON
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

AXINON Trademark

Serial Number: 79129531 • Registration: 4582191

AXINON is a trademark filed by Numares GmbH on January 22, 2013. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 45 (Legal & Security Services). The application is currently registered and active.

Owner Contact Info

Numares GmbH (2 trademarks)

Josef-Engert-Straße 9
93053 Regensburg , DE

Entity Type: 99

Numares AG (7 trademarks)

Regensburg 93053 , DE

Entity Type: 03

Trademark Details

Filing Date

January 22, 2013

Registration Date

August 12, 2014

Published for Opposition

May 27, 2014

Goods & Services

Scientific apparatus and instruments, namely, centrifuges, glass tubes, nuclear magnetic instruments in the nature of nuclear magnetic spectrometers and pipettors; scientific apparatus and instruments in the nature of automatic pipetting systems comprised of robotics for moving a sample, robotics for moving NMR tubes, and means for housing containers containing any of reagents, control substances, and calibrating substances; measuring apparatus and instruments, namely, nuclear magnetic instruments in the nature of nuclear magnetic spectrometers; testing apparatus not for medical purposes, namely, nuclear magnetic instruments in the nature of nuclear magnetic spectrometers; food analysis apparatus, namely, nuclear magnetic instruments in the nature of nuclear magnetic spectrometers; diagnosis apparatus, not for medical purposes, namely, nuclear magnetic instruments in the nature of nuclear magnetic spectrometers; laboratory equipment, namely, spectroscopes; recorded computer software, namely, analytical software to obtain results from raw data, interface software for establishing connections to laboratory software and laboratory instrumentation, software for managing workflow processes, software for database management, and software for controlling spectroscopes and nuclear magnetic instruments in the nature of nuclear magnetic spectrometers; downloadable computer programs featuring analytical software to obtain results from raw data, interface software for establishing connections to laboratory software and laboratory instrumentation, software for managing workflow processes, software for database management, and software for controlling spectroscopes and nuclear magnetic instruments in the nature of nuclear magnetic spectrometers; none of the aforementioned goods relating to androgen replacement or testosterone replacement

Chemicals in the nature of diagnostic preparations for medical and veterinary analyses in laboratories; none of the aforementioned goods relating to androgen replacement or testosterone replacement

Chemicals for use in industry and science; chemical preparations, namely, control solutions, diluents, calibrating substances, reference substances, and concentration markers for analyses of body fluids and their metabolites, and for analysis of plant extracts and extracts of fermentation processes in laboratories, other than for medical or veterinary purposes; chemical reagents other than for medical or veterinary purposes; biological preparations for use in analytic processes and for use in the identification and quantification of ingredients of chemical and biological compositions, other than for medical or veterinary purposes; diagnostic preparations, other than for medical or veterinary purposes; assortments, namely, kits of chemicals for use in industry and science for analyses of body fluids and their metabolites, of plant extracts and extracts of fermentation processes, and for the identification and quantification of ingredients of chemical and biological compositions; none of the aforementioned goods relating to androgen replacement or testosterone replacement

Licensing of computer software in the nature of legal services; licensing of intellectual property rights, namely, industrial property rights and copyright; licensing of research methods; none of the aforementioned services relating to androgen replacement or testosterone replacement

Scientific and technological services, namely, research and design in the fields of spectroscopy, of analyses of body fluids and their metabolites, of plant extracts and extracts of fermentation processes, of identification and quantification of ingredients of chemical or biological compositions, of monitoring metabolic processes, of diagnosing metabolic disorders, cardiovascular disorders, cancer, dementia and diabetes, and of monitoring the treatment of metabolic disorders, cardiovascular disorders, cancer, dementia and diabetes; industrial analysis and research services in the fields of spectroscopy, of analyses of body fluids and their metabolites, of plant extracts and extracts of fermentation processes, of identification and quantification of ingredients of chemical and biological compositions, of monitoring metabolic processes, of diagnosing metabolic disorders, cardiovascular disorders, cancer, dementia and diabetes, and of monitoring the treatment of metabolic disorders, cardiovascular disorders, cancer, dementia and diabetes; computer hardware and software design and development; biological research; computer programming; installation and maintenance of computer software; updating of computer software; rental of computer software; measurement services, namely, performing measurements for third parties in the fields of spectroscopy, of analyses of body fluids and their metabolites, of plant extracts and extracts of fermentation processes, of identification and quantification of ingredients of chemical and biological compositions, of monitoring metabolic processes, of diagnosing metabolic disorders, cardiovascular disorders, cancer, dementia and diabetes, and of monitoring the treatment of metabolic disorders, cardiovascular disorders, cancer, dementia and diabetes; research and analysis services in the fields of molecular biology, biochemistry and spectroscopy; research and development services in the fields of molecular biology, biochemistry and spectroscopy; scientific research in the fields of molecular biology, biochemistry and spectroscopy; services of medical and bacteriological research laboratories, namely, medical research and bacteriological research; services of chemical laboratories in the fields of spectroscopy, of analyses of body fluids and their metabolites, of plant extracts and extracts of fermentation processes, of identification and quantification of ingredients of chemical and biological compositions, of monitoring metabolic processes, of diagnosing metabolic disorders, cardiovascular disorders, cancer, dementia and diabetes, and of monitoring the treatment of metabolic disorders, cardiovascular disorders, cancer, dementia and diabetes; none of the aforementioned services relating to androgen replacement or testosterone replacement

Filing History

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Feb 10, 2025 NA71
REGISTERED-SEC.71 ACCEPTED
Feb 10, 2025 71AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Feb 9, 2025 APRE
TEAS SECTION 71 RECEIVED
Aug 9, 2024 ES71
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Aug 12, 2023 REM4
INTERNATIONAL REGISTRATION RENEWED
Feb 17, 2023 RNWL
NEW REPRESENTATIVE AT IB RECEIVED
Dec 31, 2022 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Nov 12, 2022 NREP
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jan 28, 2022 ADCH
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Dec 9, 2020 NA75
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Dec 9, 2020 C75A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Dec 7, 2020 APRE
TEAS SECTION 71 & 15 RECEIVED
Aug 12, 2020 ES75
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Oct 9, 2019 REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Aug 12, 2019 REM3
CHANGE OF NAME/ADDRESS REC'D FROM IB
Nov 19, 2015 ADCH
NEW REPRESENTATIVE AT IB RECEIVED
Sep 18, 2015 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 13, 2015 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jan 26, 2015 FICS
FINAL DISPOSITION PROCESSED
Jan 26, 2015 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 12, 2014 FICR
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Aug 13, 2014 LIMN
REGISTERED-PRINCIPAL REGISTER
Aug 12, 2014 R.PR
NOTIFICATION PROCESSED BY IB
Jul 12, 2014 GPNX
LIMITATION OF GOODS RECEIVED FROM IB
Jun 13, 2014 LIMG
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 27, 2014 NPUB
PUBLISHED FOR OPPOSITION
May 27, 2014 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 7, 2014 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
May 7, 2014 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 7, 2014 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Apr 18, 2014 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 11, 2014 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 3, 2014 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 2, 2014 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 2, 2014 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 7, 2013 GNRN
NON-FINAL ACTION E-MAILED
Nov 7, 2013 GNRT
NON-FINAL ACTION WRITTEN
Nov 7, 2013 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 16, 2013 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 16, 2013 CRFA
ASSIGNED TO LIE
Oct 10, 2013 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 8, 2013 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 7, 2013 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 7, 2013 REAP
REFUSAL PROCESSED BY IB
Jun 24, 2013 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 28, 2013 RFCS
REFUSAL PROCESSED BY MPU
May 28, 2013 RFRR
APPLICATION FILING RECEIPT MAILED
May 28, 2013 MAFR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 26, 2013 RFCR
NON-FINAL ACTION WRITTEN
May 25, 2013 CNRT
ASSIGNED TO EXAMINER
May 23, 2013 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 23, 2013 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
May 22, 2013 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 16, 2013 REPR